- Home
- EM vs MDWD Comparison
EM vs MDWD Comparison
Compare EM & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- MDWD
- Stock Information
- Founded
- EM 2017
- MDWD 2000
- Country
- EM China
- MDWD Israel
- Employees
- EM N/A
- MDWD N/A
- Industry
- EM Other Consumer Services
- MDWD Medicinal Chemicals and Botanical Products
- Sector
- EM Consumer Discretionary
- MDWD Health Care
- Exchange
- EM Nasdaq
- MDWD Nasdaq
- Market Cap
- EM 289.1M
- MDWD 208.2M
- IPO Year
- EM 2021
- MDWD 2014
- Fundamental
- Price
- EM $1.14
- MDWD $19.74
- Analyst Decision
- EM Hold
- MDWD Strong Buy
- Analyst Count
- EM 1
- MDWD 2
- Target Price
- EM $1.25
- MDWD $35.00
- AVG Volume (30 Days)
- EM 88.2K
- MDWD 47.9K
- Earning Date
- EM 08-21-2025
- MDWD 08-13-2025
- Dividend Yield
- EM N/A
- MDWD N/A
- EPS Growth
- EM N/A
- MDWD N/A
- EPS
- EM N/A
- MDWD N/A
- Revenue
- EM $259,541,587.00
- MDWD $19,213,000.00
- Revenue This Year
- EM $3.30
- MDWD $20.80
- Revenue Next Year
- EM $5.26
- MDWD $26.92
- P/E Ratio
- EM N/A
- MDWD N/A
- Revenue Growth
- EM N/A
- MDWD N/A
- 52 Week Low
- EM $0.50
- MDWD $14.14
- 52 Week High
- EM $1.17
- MDWD $22.51
- Technical
- Relative Strength Index (RSI)
- EM 57.55
- MDWD 50.69
- Support Level
- EM $1.12
- MDWD $19.07
- Resistance Level
- EM $1.17
- MDWD $19.55
- Average True Range (ATR)
- EM 0.03
- MDWD 0.56
- MACD
- EM -0.00
- MDWD -0.03
- Stochastic Oscillator
- EM 56.25
- MDWD 88.89
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.